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INTRODUCTION
Cancer is a major cause of morbidity and mortality 
in developed countries and of increasing concern in 
developing countries. Its treatment is often costly and 
associated with high mortality, whereas screening 
and early diagnosis is life saving. 
 Epidemiological surveys indicate that patients 
with certain cancers often have a family history of 
cancer (1). Familial cancers with clear patterns of 
mendelian inheritance are very rare. However in the 
past decade many genes responsible for these rare 
disorders have been identiﬁed (1). 
 The cancer genes characterised and known 
inheritance patterns are associated with speciﬁc cancer 
syndromes comprising two or more malignancies 
in “cancer families”. Targeted genetic testing and 
screening of susceptible individuals is being carried 
out in developed countries. For example it has been 
found that screening and genetic testing (for BRCA 1 
and 2 genetic markers) reduces breast cancer mortality 
and has important implications in the natural history 
of the disease. Evidence suggests that metastases 
occur very early in breast cancer and it should be 
considered a systemic disease from the onset due 
to delay in diagnosis of majority of cases. Studies 
show that targeted surveillance, therefore earlier 
screening of women with a family history of breast 
cancer leads to improved survival (2). Breast cancer 
is the most common malignancy in women in Kenya 
making up 23.3% of women cancers (3). In the Kenyan 
woman, it occurs more in premenopausal ages, is a 
more aggressive disease presenting with metastases 
in 88% of the cases, with higher grades but similar 
histological types to white women (4). There is lower 
postitivity both endochrine receptors and Her/neu 2 
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ABSTRACT
Objective: To describe the occurrence of cancers in families of individuals diagnosed 
cancer. 
Design: Cross-sectional descriptive study. 
Setting: Outpatient cancer clinics at Kenyatta National Hospital (KNH) and Radiotherapy 
Clinic at Nairobi Hospital. 
Subjects: Patients with a tissue histological or cytological diagnosis of cancer. 
Main outcome measures: A reported family history of cancer. 
Results: A total number of 485 cancer patients were recruited, 382, from KNH and 103 
from Nairobi Hospital. These index cases had 45 different types of cancer, with the 
most common being breast and uterine-cervical malignancies. Prevalence of family 
history of cancer was found to be 18.8% and was highest among 1st degree relatives. 
Documentary evidence was seen in 48.4% and history of cancer corroborated by 
medical personnel in an additional 11%. In 18.7% of cases more than one relative was 
interviewed to conﬁrm the family history of cancer. Educational levels of the index 
cases correlated with knowledge of family history of cancer, with those of higher 
educational level having been more informed about their families’ medical history. 
There was a prevalence of familial cancers of 30% at Nairobi Hospital patients and 
15.7% at KNH patients. 
Conclusion: We found the prevalence of family history of cancer in our population to 
be 18.8% and was highest among 1st degree relatives. This has implications for targeted 
screening and therefore early diagnosis which is beneﬁcial. 
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receptors (5), which correlates with poorer prognosis. 
African American women have similar poor prognostic 
indicators and a 37% higher mortality than white 
women, in  whom early referral and treatment is aimed 
at (6). In our setup high risk individuals from “cancer 
families” can undergo targeted screening that can be 
cost effective and life saving. 
MATERIALS AND METHODS
Cases were recruited from KNH medical, surgical and 
radiotherapy outpatient clinics and Nairobi Hospital’s 
radiotherapy unit. Most cancer patients seen at KNH 
were outpatients due to the hospital policy of limiting 
admission of chronic patients. KNH inpatients were not 
included because of logistics of covering all the wards, 
difﬁculty in consecutive sampling of inpatients and 
potential for selection bias. The KNH radiotherapy clinic 
operates as outpatient oncology follow-up clinic. 
Inclusion and exclusion criteria: Patients with a 
documented diagnosis of cancer who consented to 
participation in the study were recruited. Secondary 
malignancies, such as HIV and post-transplant 
associated cancers were excluded. 
 Two research assistants assisted in screening the 
daily clinic attendance ﬁles for histological report 
of cancer. These patients were approached using a 
standardised information sheet. A written informed 
consent was obtained. 
 The principal investigator administered a 
standardised questionnaire to all the index cases 
and accompanying relatives. If no relative had 
accompanied the patient, their relatives were contacted 
and interviewed. A follow-up was made to interview 
other relatives who corroborated the presence or 
absence of a family history of cancer. Contact telephone 
numbers and addresses of relatives to be interviewed 
were provided by the index cases. 
 Cancer type and demographic details of the index 
case were documented. Family history of cancer in 
patient’s ﬁrst and second degree relative was sought. 
A detailed family medical history of these relatives 
was taken. An “important-other” family member, 
based on educational level, prominence and inﬂuence 
in the family and a willingness to cooperate with 
the investigator, was identiﬁed and interviewed in 
person, via telephone or mail, seeking to conﬁrm 
the family history as reported by index case and 
accompanying relatives. Cancer type, institution 
where diagnosis was made, attending physician, year 
of diagnosis, follow-up clinic as well as demographics 
of the other relative with cancer were noted. This 
helped in accessing documentary evidence of the 
same. If alive the relative with cancer was interviewed 
in person or via telephone contact. 
 Documentary evidence of the relatives’ 
with cancer was also sought from the existing 
cancer registries in KNH and KEMRl (Kenya 
Medical Research Institute), other hospital records, 
death certiﬁcates, pathology reports and verbal 
corroboration from attending physicians were sought. 
Consequently the level of evidence, of a family history 
of cancer was categorised on basis of level of cross 
validation as follows: 
 Conﬁrmed: Documentary evidence obtained ,such 
as hospital discharge summaries, record cards, DXT 
cards ,histology reports, prescriptions and perusal 
of attending physicians’ notes. 
 Highly probable: Verbal conﬁrmation of history by 
relatives who were medical for example doctors, clinical 
ofﬁcers or nurses, as well attending physicians. 
 Probable: Verbal corroboration from patient and 
two other relatives including the “important-other 
relative”. 
 Least probable: Verbal conﬁrmation from patient 
and any other relative. 
RESULTS
Five hundred and thirteen cases were screened and 485 
were recruited during the period of June to November 
2003; 78.8% of sample from KNH, and 21.2% from 
Nairobi Hospital. Male to female ratio was 1:1.5 and 
age ranged from 13 to 93 years, with 44% in the 31 to 50 
years age group and 16.7% in 60 to 80 years. Sixty eight 
per cent drawn from rural and 32% from urban areas. 
They were mainly from Central province, followed by 
Nyanza, Eastern and Coast provinces. This follows 
the referral patterns of outpatients attending clinics 
in KNH. The ethnicity of index cases also follows 
the catchments area of the two hospitals implying 
unbiased sampling. 
 Educational levels of the index cases were: 17.3% 
no formal education, 37.7% primary, 28.7% secondary 
and 16.3% tertiary level. The Nairobi Hospital cohort 
had higher levels of formal education while 64% of 
KNH cohort had primary level education or had 
received no formal education at all. 
 Index cases had 45 different cancer types, with 
the most frequent being breast (13.8%) and uterine 
cervix (14%). Post-nasal tumour (11%), skin cancers 
(6.9%), non PNS head and neck tumours (6%) and 
laryngeal cancers 5%. 
 A prevalence of family history of cancer was 
established in 18.8% (95% C.I 15 22%). Prevalence of 
positive family history was 12.4% among 1st degree 
relatives and 6.4% in 2nd degree relatives. Some 
families had a multiple family history of cancer; 25% 
had more than one relative with cancer, two cases 
had four relatives each with cancer. A total of 125 
relatives had cancer from 91 index cases 
 Family history of cancer was validated as conﬁrmed 
or highly probably in 59.4% of cases (Table 1). On 
stratifying according to hospital and educational level 
of index cases, a higher prevalence of positive family 
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Table 2
Differences in familial clustering in the breast cancer and uterine cervix cancer
Cancer type Cancer of Cancer of Cancer PNS Total
 breast cervix
Family HX of CA 24 (36%) 14 (21%) 7 (13%) 45
No Family HX of CA 42 53 46 141
Total 66  67 53 186
Chi - Square Calculation: 
Degrees of freedom 2 
Chi - square =9.21511699921617 
X2= 9.2 P<0.01 
This distribution is signiﬁcant
Figure 1
Age distribution of relatives with cancer
history was found among those of higher educational 
attainment and among the Nairobi Hospital cohort 
(30%; 95% CI 0.55.20), in contrast to the prevalence in 
the KNH cohort ( 5.7% (CI 0.54-.20) (Table 2).
Table 1
Prevalence of a family history of cancer according to 
institution and education level
Hospitals/ KNH KNH FHx NRB NRB
Education  of Hosp FHX of
Level  cancer   cancer
None 70 6 14 2
Primary 176 7 7 5
Secondary 107 24 32 8
Tertiary 29 23 50 16
Total 382 60 (15.7%) 103 31 (30%)
Approximately 16.8% of relatives were living, half 
of whom were interviewed, while 83.2% were dead. 
Relatives with cancer had an age distribution skewed 
to the right and majority were aged over 60 years 
(Figure 1) and of male gender (54%). 
 There were 61% ﬁrst degree relatives and 39% 
second degree relatives among the relatives with 
cancer. Of the 66 breast cancer index cases 36% had 
a family history of cancer; 66% were ﬁrst degree 
relatives and 34% were second degree relatives. 
There were 67 index cases with cancer of cervix, of 
these 21% had a family history of cancer and 43% 
were ﬁrst degree relatives and 58.2% second degree 
relatives. There were 125 relatives with 24 different 
cancers, the most common being cancers of uterine 
cervix and breast; a frequency pattern similar to that 
of index cases (Figure 2). 
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Figure 2
The common cancer types among relatives of index cases
DISCUSSION
We found a prevalence of familial clustering of cancer 
of 18.8% (95% C.I 15 - 22%). This is the ﬁrst such data 
in this region, as no data is available for sub-Saharan 
Africa but our data correlated with Western data in 
several areas. The general population risk for various 
malignancies ranges from 5 -25% (7,8). In Utah and 
California combined data on 44,788 pairs of twins 
showed increased familial risk among twins of 
patients with stomach, colorectal, lung, prostate and 
breast  malignancies (9). We found a familial clustering 
of 36% in breast cancer patients, while a Stockholm 
study showed 35% in breast cancer as well, with a 
younger age of onset in the familial group (10). All 
these studies used cancer registry data in contrast 
to recall as utilised in our study. Our ﬁnding may be 
an underestimate due to the various biases limiting 
veriﬁcation of the family history of cancer. Recall 
bias was a major shortcoming of this study. Under 
reporting on account of illiteracy, lack of inter-family 
communication, geographical constraints, stigma 
of the disease and conﬁdentiality issues can be 
expected to have biased our ﬁnding to the null. Poor 
record keeping and lack of updated cancer registries, 
limited veriﬁcation of the information obtained. Over 
estimating on account of misclassiﬁcation bias was 
minimised by veriﬁcation of information at various 
levels. Limiting the analysis to veriﬁed conﬁrmed 
family history of cancer gave a prevalence’s similar 
to those in studies in which cancer registries were 
utilised. 
 Survival bias limited recruitment of cancer types 
that are rapidly fatal, as depicted by only three cases 
of hepatocellular cancer yet it is among the top ﬁve 
malignancies in our country. 
 Our ﬁndings are generalisable to the Kenya 
cancer population; ﬁrstly because our sample was 
unbiased, as is evident from the similar national cancer 
frequencies (11) and demographics of the index cases 
to those of other chronic disease patients attending 
outpatient clinics at the KNH (12). Secondly, KNH is 
the only national cancer referral treatment centre and 
third, the general population lack of awareness about 
possible familial clustering of cancer is not expected 
to have contributed signiﬁcantly to a referral bias. 
As reported in European studies, we documented 
a higher prevalence in ﬁrst degree as apposed to 
second degree relatives, and we view this as further 
validation evidence (13). In some studies monozygotic 
twins have higher cancer risk than dizygotic twins 
of cancer patients (14). 
 Uterine cervical cancer in our sample did not have 
a strong familial predilection as has been similarly 
reported in epidemiological data from the US and 
Europe with the occurrence being predicted more 
by environmental factors such as number of sexual 
partners, age at ﬁrst intercourse and HPV infection 
(15). Investigators reporting clustering of cervical 
cancer in families have argued that these individuals 
shared the same environment and have common 
lifestyle patterns hence tendency to be infected with 
HPV (16). 
Cancer type
   1        2    3        4        5         6         7        8        9         10      11       12      13       14       15      16      17       18      19      20        21      22      23       24      25      26        27
1.   Ca Cervix
2.   Ca stomach
3.   Sq Cell ca
4.   Ca PNS
5.   Ca Breast
6.   Ca Skin
7.   Multiple Myeloma
8.   Ca Vulva
9.   Ca Larynx
10.  Ca Brain
11.  NHL
12.  Ca Oesophagus
13.  Osteogenic sarcoma
14.  Hodkins lymph
15.  CLL
16.  Ca Ovary
17.  ALL
18.  Ca colon
19.  Ca Jaw
20.  Ca Prostate
21.  Ca Mouth
22.  Chondrosarcoma
23.  Ca Thyroid
24.  HCC
25.  Ca Rectum
26.  Malgnant Melanomna
27.  Ca abdominal wall
KEY
Number of cases
January 2010 EAST AFRICAN MEDICAL JOURNAL   13
 Whereas cancer is generally a disease of the 
elderly population, due to increased susceptibility 
as duration of exposure to carcinogens increases, 
the relatively younger age distribution in our study 
is a reﬂection of higher frequency of early occurring 
female gender cancers. In Western literature the 
common associations of parity, early age of delivery 
were not protective against ovarian cancer in those 
with a strong family history of cancer (17). 
 In conclusion we found a prevalence of familial 
clustering of cancer s in our setup to be approximately 
18.8% and is highest amongst ﬁrst-degree relatives 
at 12% compared to 6% for second-degree relatives. 
Breast cancer had a familial clustering prevalence 
of 36% and a same cancer concordance rate of 54%. 
Multiple family history of cancer was highest in 
breast cancer cases. If an early diagnosis of cancers is 
made, many lives can be saved and cost of treatment 
reduced. An awareness of familial risk of cancer is 
important towards this end. Targeted screening of 
these family members will aid in early diagnosis and 
therefore reduce morbidity and mortality of the two 
most common malignancies in our environment. 
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